CVS vs. Walgreens | The Doctor is In | 4

1 Nov 2023 · 36 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Business Wars Podcast Episode Summary: CVS vs. Walgreens | The Doctor is In | Episode 4

Episode Overview Host: David Brown Release Year: 2013 Focus: Examines the strategic decisions made by CVS and Walgreens in light of evolving healthcare demands and market pressures.

Key Themes

  • Corporate Strategy: The episode highlights significant corporate decisions by CVS and Walgreens, focusing on how each company responds to competitive pressures and changing consumer health needs.
  • Healthcare Partnerships: The importance of aligning with healthcare providers and the impact of public perception regarding tobacco sales on corporate partnerships is explored.
  • Market Dynamics: The episode discusses how mergers and acquisitions shape market positions and influence company strategies.

CVS Decision to Remove Tobacco

  • Leadership: CVS CEO Larry Merlo embarks on a plan to stop selling cigarettes, aiming to improve CVS's public image and facilitate partnerships with healthcare providers.
  • Financial Impact: Merlo requests board approval to remove $2 billion in tobacco sales, arguing for long-term health benefits over short-term sales loss.
  • Personal Motivation: Merlo shares a personal story about his father’s death from smoking, which resonates with board members and aids in gaining their support.
  • Public Announcement: In February 2014, CVS announces it will stop selling tobacco, causing an immediate drop in stock but garnering praise from health organizations.

Walgreens Response

  • Positioning: Unlike CVS, Walgreens does not eliminate tobacco sales, arguing that their business model incorporates tobacco revenue without the same healthcare ties.
  • Corporate Pressure: Walgreens CEO Greg Wasson faces pressure from investors to relocate the company's headquarters to Switzerland for tax benefits, which sparks public backlash and ultimately leads to a decision to remain in the U.S.
  • Mergers and Acquisitions: The company is simultaneously finalizing the acquisition of Alliance Boots, which presents its own challenges and opportunities amid market changes.

Competitive Strategies

  • CVS's New Direction: Following the tobacco exit, CVS focuses on expanding healthcare services, including acquiring Target's pharmacy operations to increase reach.
  • Walgreens Partnerships: Walgreens opts for strategic partnerships, like investing in Village MD, which places primary care physicians within their stores, differing from CVS's direct acquisitions.

Regulatory Challenges

  • Antitrust Concerns: Walgreens faces scrutiny over its acquisition of Rite Aid, with regulators concerned about market monopolization.
  • Healthcare Accountability: The opioid crisis leads CVS, Walgreens, and others to face significant lawsuits and financial settlements, reflecting the complexities of their roles in public health.

Conclusion The episode encapsulates a pivotal moment for both CVS and Walgreens as they navigate the evolving landscape of healthcare retail, balancing ethical considerations, financial realities, and competitive strategies. The decisions made during this period set the stage for their future roles in the American healthcare system, highlighting the significant influence of corporate actions on public health outcomes.

Key Takeaways

  • CVS's strategic exit from tobacco sales demonstrates a shift towards a healthcare-centric model, emphasizing long-term benefits over short-term profits.
  • Walgreens's choice to retain tobacco sales illustrates a contrasting strategy focused on maintaining revenue streams amidst pressures for innovation and change.
  • The merger of CVS with Aetna signifies a transformative moment in the pharmacy industry, integrating healthcare services with pharmacy retail.

---

This episode highlights the critical decisions impacting CVS and Walgreens as they adapt to meet healthcare needs and navigate the complexities of corporate responsibility and market competition.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:07It's 2013 on CVS Caremark's sprawling corporate campus in Woonsocket, Rhode Island. In a large meeting room with floor-to-ceiling windows overlooking manicured lawns, CVS boss Larry Merlo is giving a presentation to a major health care provider, and the excitement is building. He and his team want to forge a multi-million dollar partnership with this health care provider. They hope it will drive more patients through CVS's doors, and so far Merlo's audience seems keen. Merlo moves to the last slide of his sales pitch. Visitors from the health care provider lean forward in their seats. Finally, I'd like to share some results from our efforts at CVS to improve our customers' medical adherence.

0:50The health care team excitedly jots down the figures on the screen. Medical adherence, or staying on a prescribed medication, is a big deal for this health care provider. Patients who don't regularly take their meds generally get sicker and end up having unnecessary medical treatments. They cost America an estimated$290 billion every year. It's also a problem for CVS, because if people aren't taking their meds, they're not refilling their prescriptions at CVS. Merlo highlights the figure he knows will impress his visitors the most. As you can see, with our adherence outreach program, patients are 25 % more likely to obtain their refill.

1:30Sounds good. Right? The visitors' eyes widen. They could save tens, maybe hundreds of millions if they don't have to pay for all those unnecessary hospital treatments caused by patients not taking their medicine. And at the same time, CVS will profit from all those refills. It's a win-win arrangement. Merlot's Super Mario mustache turns up into a smile. Maybe this time, everything will come together. But then, one of the healthcare company team raises his hand. Please, ask away. Larry, this is all fantastic, but I'm concerned about the optics here. We're a health care company, and you, well, you sell cigarettes.

2:16Isn't it a bad look for us to be working with a cigarette retailer? Merlot's upturned mustache droops. The rest of the CVS team sink lower in their seats. The excitement in the room vanishes. The executive from the health care provider presses his point home. We're a health care company. I mean, how can we direct patients to CVS when it's one of the biggest tobacco retailers in America? There is that. That's a good point. Yeah. The guy's colleagues nod. Merlot cringes. The problem of selling cigarettes is happening again. Time after time, CVS gets close to striking a major health care deal, only for it to be scuttled at the last moment because CVS won't stub out its tobacco habit.

3:03The head of the visiting delegation stands up. Merlo looks alarmed. You're leaving? Larry, everyone. This was really exciting. Come on, let's at least talk it through. I'm sorry, Larry, but the tobacco issue, that's an insurmountable problem. We're a medical company. We can't partner with a company that sells cigarettes. Merlo tries to salvage the fast disappearing deal. Come on, at least stay for lunch. Thank you, but no, we should get back. We've got a long journey ahead. Merlo watches the visitors file out of the room. Inside, he's fuming. Tobacco's holding CBS back and endangering its future.

3:46Merlo knows it's got to go. But quitting won't be easy. Because to do it, Merlo must convince CBS's board to let him snuff out sales worth$2 billion a year.

4:05When planning for your future, you want someone with a history of keeping their word year after year. For nearly 160 years, Pacific Life has been a trusted name in the industry. But that isn't just a number. It's experience that matters. It's 160 years of promises held, helping generations retire with confidence, protect their loved ones, and plan for whatever comes next. Whether you're looking for life insurance, employee benefits, or retirement income solutions, when your future is on the line, you want history on your side. And believe me, Pacific Life has been there, always there through changing times, always focused on your needs.

4:44Ready to secure your tomorrow? Ask a financial professional how Pacific Life can help you feel prepared for what's next. Pacific Life Insurance Company, Omaha, Nebraska, and in New York, Pacific Life and Annuity, Phoenix, Arizona. because with Pacific Life, you're not just planning for the future, you're partnering with trusted experience. Closing the books, getting your people paid, and bringing on new hires. Running a small or mid-sized business can be exciting and also a little chaotic. Workday Go makes simplifying your business, well, simple. Imagine all the important aspects of your company, HR, finance, and payroll, all on the AI platform.

5:25No more juggling multiple systems, no more worrying about growing too fast. Just the full power of Workday Go, helping small to mid-sized businesses like yours scale and run more smoothly. Think about what that means. Seamless onboarding for new team members, real-time insights at your fingertips, and payroll that works perfectly every single time. So you can focus on the big picture and go after your big ambitions. And with Workday, you can activate quickly in as little as 30 to 60 business days. So simplify your business. Go for growth. Go with Workday Go.

6:08From Wondery, I'm David Brown, and this is Business Wars.

6:36On the last episode, CVS tried to use Caremark to press Walgreens into lowering the profits it makes from filling prescriptions. Walgreens limped away from its battle with Express Scripts, and Italian billionaire Stefano Pessina agreed to sell Alliance boots to Walgreens. Now, Walgreens is stepping onto the world stage as it prepares to complete its acquisition of Pessina's European pharmacy empire. But it won't be the coronation it was expecting. CVS, meanwhile, is looking to quit smoking so it can charm the healthcare industry. This is Episode 4, The Doctor Is In.

7:22January 2014. In the CBS boardroom in Woonsocket, Rhode Island, CEO Larry Merlo is a wreck. Bags under his eyes betray sleepless nights in anticipation of this dreaded moment. He's about to ask the company's board of directors to back a plan to inflict major damage to CBS's finances. Merlo looks down the long boardroom table. The faces of CBS's directors stare back at him. He's primed a few of them in advance about his plan, but most of them will be hearing of it for the first time today, and there's no telling how they'll react. Merlo takes a deep breath, then starts talking. Our strategic goal is to pursue growth opportunities in health care, but many health care providers will not work with us because we sell tobacco.

8:14So, today, I'm asking you to support my decision to stop selling tobacco in our stores. One of the board members responds. Okay, Larry, but what impact is this going to have on the business? Tobacco accounts for around$1.5 billion of our annual revenues. Associated products like breath mints add another half billion. It's not just tobacco sales that are on the line. It's everything that smokers buy at CVS, from chewing gum to disposable lighters and more. So you want permission to eliminate$2 billion of CVS's sales? Yes, but this is short-term pain for long-term gain. Tobacco sales are in decline, and the healthcare companies we want to work with don't want to work with us because we sell cigarettes.

9:05So we have to stop selling cigarettes. Another director pipes up. Okay, where does this end? We get rid of tobacco, then what? People will go, oh, actually, soda, chips, candy, and liquor aren't good for you either. So do we remove those from the stores too? Merlo smiles. I asked myself that exact same question. So I did some low-key surveys of health professionals, and they told us, yes, there are health issues with those other products, but in moderation, they're fine. Cigarettes, however, they're addictive. They're dangerous. Merlot wavers for a moment and then makes the argument personal. Also, when we examined the pros and cons of this, there was one thing that became very clear.

9:49Most people have lost folks they love to smoking. My own father smoked. He died at age 57. Tobacco robbed me and him of the time we could have spent together. This is the right thing for us to do. The directors fall quiet. They, too, have lost people to tobacco. Nearly 450 ,000 people a year die in the United States because of tobacco. The company's chairman breaks the silence. I support the plan. Does anyone object? Objection here. The directors shake their heads. The chairman smiles. Then that's agreed. Larry, you have our backing. One director looks Merlot in the eyes. And Larry, don't just do this.

10:36Make sure you tell the world about it, okay? Larry does just that. In February 2014, CVS announces it will stop selling tobacco. Announcement this morning from CVS. The national drugstore chain is phasing out the sale of cigarettes, a move that could cost billions in sales. And ABC's Rebecca Jarvis here to explain why. Good morning, Rebecca. George, good morning. It is the first and largest drugstore chain to take this monumental step. And here's a first look at an ad that will be running tomorrow in newspapers across the country. CVS quits for good. The announcement knocks CVS's stock down 7%, but politicians and physicians shower the company with praise.

11:20The move also places Walgreens under heavy political pressure to follow suit. Within days, 28 state attorneys have written to the company urging it to follow CVS's lead. But for Walgreens, the equation's different. Unlike CVS, Walgreens doesn't own a pharmacy benefits manager. CVS can ditch cigarettes and recoup the lost sales by getting more health plans signed up with Caremark. But for Walgreens, there's no upside to the sales sacrifice. So it doesn't change course. But tobacco is not the only reason Walgreens is facing political heat.

12:06In a Four Seasons hotel suite with views of the Eiffel Tower, Walgreens boss Greg Wasson is outnumbered. It's April 2014, and with him in the room are representatives from Goldman Sachs and three powerful hedge funds. And they all want Walgreens to move its headquarters to Europe. One of the hedge fund executives presses the case. Relocating to Switzerland is the smart move, Greg. It'll wipe hundreds of millions off Walgreens' tax bill. Wasson bristles. Walgreens is finalizing its plan to buy and merge with the European pharmacy giant Alliance Boots. But that's raised the question of where the merged company will be based.

12:48Six months ago, Wasson declared that Walgreens would stay in America. Now, these major investors want him to reconsider. The hedge fund executive keeps pushing. It's instant value for stockholders. You have a fiduciary responsibility to do what's best for them. This will cause major fallout in the United States. The political and consumer backlash would be enormous. Wasson glances at Stefano Pessina, the white-haired 72-year-old chairman of Alliance Boots. But the Italian billionaire disagrees. He's been here before with the British drugstore chain Boots. We moved Boots' tax base from Britain to Switzerland, and it reduced our tax bill by$160 million.

13:31This'll be the same, but much, much bigger, Wasson interjects. There were protests, remember? Cassina shrugs. Well, the protesters were wrong. We used the money we saved to create wealth, and people still shop at Boots. It'll be the same with Walgreens. Wasson isn't so sure. Well, America's pharmacy trade is more competitive. But Boots doesn't have to worry about people switching to CVS. And don't forget many stockholders will get hit by the IRS for capital gains tax if we move to Switzerland. Another of the hedge fund managers leans forward. It won't affect stockholders outside America, pension funds or mutual funds.

14:14I'm talking about individual stockholders. Plenty of them are American. The majority of stockholders will be better off. The first hedge fund manager moves in again. Let's table this for a moment. I'd like to talk about what happens after you buy Alliance Boots. Wasson nods. All right. We'd like to see members of the Alliance Boots team in key positions. Wasson glances at Pessina. Frankly, Walgreens is underperforming. In the past ten years, Walgreens stock dropped 7 % while CVS stock rose 200%. Walgreens needs to deliver better products and reduce overhead. We believe it should use every tax advantage at its disposal, including moving to Switzerland.

15:00I'll give the tax inversion due consideration. It's instant shareholder value. The tax bill will be reduced by billions. I'll consider it, but I'm still concerned about the political risk to the brand and the company. The meeting ends without a decision, But Wasson and his team are now contemplating relocating to the Alps. And in the United States, that ignites a public backlash.

15:34It's July 2014, and outside the Wrigley Building in Chicago, a few dozen protesters are holding up handwritten signs bearing slogans like, Stay in the USA! And don't go offshore. They've come to deliver a petition signed by 70 ,000 people to Walgreens' flagship store. And they're angry. The corporation first opened its store here in Illinois in 1901. But now its executives and a small faction of its shareholders are giving serious thought to moving its corporate address to Switzerland, thereby abandoning America. That ain't right. That ain't right. And why? Because Switzerland is a tax haven. And as Walgreens mulls over whether it should stay or go, the outrage keeps building.

16:22President Barack Obama and members of Congress join the critics' chorus. Soon, there's talk of legislation to stop companies from relocating overseas solely to duck taxes. Faced with the mounting anger, Wasson announces that Walgreens will stay in America. But then, another bombshell hits the drugstore giant. In July 2014, the company announces it miscalculated its pharmacy sales forecast by a whopping$1.1 billion. It's a stunning stumble, and it shatters investor confidence in Walgreens management. With a$16.2 billion buyout of Alliance Boots imminent, alarmed investors are looking for change at the top.

17:11And that plays right into the hands of Stefano Messina.

17:22December can be a busy month for all of us. Finishing projects, planning for next year, maybe even wrapping a few presents, while your teams take a well-deserved break. Cyber threat actors don't. Stay protected this holiday season with Manage Engine. Their cybersecurity solutions ensure that your data is secure. even while your office lights are turned off. With 18 data centers around the world and over 20 years of experience securing global enterprises, Manage Engine can keep your business running safely, no matter how busy or hectic the world gets. This holiday, gift yourself and your business peace of mind.

18:01Visit cybersecurity.manageengine.com. That's cybersecurity.mangine.com.

18:35offer in minutes. Subject to credit approval, Apple Card issued by Goldman Sachs Bank USA, Salt Lake City branch. Terms and more at AppleCard.com.

18:57On the trading floor of the Nasdaq Stock Exchange in New York, Greg Wasson hollers and claps as the opening bell rings out and blue and green confetti rains down. It's January 9th, 2015 and Walgreens Boots Alliance has just been born. The three-year engagement is over. The American drugstore giant and Europe's top pharmacy company are now wed. And they are a power couple with more than 12 ,600 stores and a worldwide drug distribution network and a total value of $116 billion. But Wasson's no longer the boss. That title now belongs to the billionaire to his right. Stefano Pessina hugs Wasson and grins ear to ear.

19:46He's just pulled off the greatest deal in a lifetime of deal-making. Officially, Walgreens bought the smaller Alliance boots, but in practice, This is a Pacina takeover of the U.S. drugstore chain. When Walgreens asked to buy Alliance Boots in 2012, the U.S. giant was struggling. CVS was powering ahead, and Walgreens' showdown with Express Scripts had caused a consumer exodus. Walgreens needed a win, and Pacina was pleased to help for a price. Walgreens paid$17.4 billion in cash and stock for Alliance Boots. Piscina now emerges with a 13 % stake in Walgreens Boots Alliance and the title of CEO.

20:35It's a dazzling coup. Piscina's persuaded Walgreens to pay billions to be taken over by Alliance Boots. But as Piscina settles into his new corner office in Deerfield, Illinois, and fills the upper ranks with executives from Alliance Boots, CBS ups its retail game.

21:00In Rhode Island, CVS Pharmacy's 50-year-old president, Helena Foulkes, is getting in the Christmas spirit. She strolls through a CVS aisle packed with festive merchandise, from Santa hats to plastic trees. But there are no shoppers in this CVS, just her and the team who are preparing the chain for the holidays. And that's because it's a hot summer day in 2015, and this CVS is the test store on the company's sprawling corporate campus in Woonsocket. Folks stops next to a display of Christmas stockings. Each stocking has one big letter monogrammed on it. She turns to the holiday decorations buyer.

21:41Are we going to have to carry every letter of the alphabet? No, no, we have data on what letters sell best. It varies by location, but the most popular are S, M, J, and C. Folks moves on, roaming every aisle. In a few months, every CVS will resemble this place. But the real challenge for Folks is how to make up for the loss in tobacco sales. Taking tobacco off its shelves may have helped CVS's pharmacy benefits manager Caremark win new business worth many millions. But it also burned a$2 billion hole in its drugstore sales and reduced foot traffic in stores. So Folks is out to rekindle sales by shifting CVS towards a healthier mix of products.

22:28And those changes are already evident in the mock-up store. The candy aisle is further away from the checkouts, and space is being given to other snacks with a healthier image. The soda bottles that once dominated the coolers are now making way for more water and other less sugary options, which more and more shoppers are moving towards. It's not just in food and drink where the health drive is evident. Even the beauty section gets a makeover, giving prime real estate to cosmetics that claim health benefits. CVS is betting that Americans now want healthier options. But Walgreens isn't eager to take the wager.

23:08Walgreens isn't interested in nudging customers into changing their habits and ways, but it is into hedging its bets. So it sells cigarettes while also offering options to help people stop smoking and balances out the candy bars by adding fresh fruit to stores. But there is one thing the two chains agree on, that bulking up is the best defense against the relentless pressure from profit-squeezing pharmacy benefit managers. In June 2015, CVS spies a new opportunity and lunges for it. From the ABC 15 Live desk and getting brand new details on that mega merger that was just announced, CVS Health will acquire Target pharmacy and clinics.

23:54The deal is worth nearly$2 billion. The deal gives CVS control of the 1 ,600 pharmacy counters inside Target's stores. And it's a win for both companies. Target frees itself from money-losing pharmacies while keeping the shoppers who drop in to get their medication. CVS, meanwhile, gets millions of Target customers and boosts its store count to 9 ,700 pharmacies. And that puts Walgreens behind again. But Walgreens boss Stefano Pesina is about to fix that.

24:34It's October 2015, and Pesina's on an earnings call to Wall Street analysts. And they all want the lowdown about his latest acquisition move. As the analysts listen in, Pessina enthuses about his deal. This is an exciting time for us. Today we're announcing the acquisition of Rite Aid. Pessina's bidding$9 billion in cash to buy 4 ,600 Rite Aid stores. It's a very steep gamble, but he expects it will pay off. The deal would catapult Walgreens ahead of CVS again and unlock efficiencies that help Walgreens counteract the dwindling prescription drug profits. But the analysts on the line see trouble ahead.

25:17Hi, Stefano. First, congratulations on the Rite Aid acquisitions. But doesn't this open you up to antitrust problems? The question lingers for a moment. Together, Walgreens and Rite Aid will own around 46 % of America's pharmacy market. But Pesina still believes the market's too fragmented. Of course, before we made this decision, we analyzed things very carefully. But, you know, when we have regulators, it's better for us not to comment. But Pessina is confident regulators will approve the acquisition of Rite Aid. The overlap between Rite Aid and Walgreens stores is mainly in a few coastal states like New York and Pennsylvania.

25:59He expects he might have to sell a few Rite Aids there and sees no reason why he can't walk away with most of its stores anyway. But federal regulators are all over this deal from day one. the Federal Trade Commission orders a review of whether the union of Walgreens and Rite Aid will stifle competition. The regulatory pressure on Walgreens is building, and not just for antitrust concerns. Federal regulators also smell trouble with Theranos, the Silicon Valley startup that Walgreens had partnered with to offer rapid blood tests. Walgreens hoped the rapid tests would give it a decisive edge over CVS.

26:39But in early 2016, regulators spot serious problems with the accuracy of Theranos' tests that could endanger patients' health. Indeed, there is blood in the waters. Walgreens severs ties with Theranos and sues the company, only to be sued itself by customers who receive flawed results from Theranos tests conducted at their stores. And while Walgreens struggles to put the Theranos debacle behind it, its battle to get its buyout of Rite Aid approved rumbles on. A year comes and goes without a resolution. To move things along, in January of 2017, Walgreens offers to sell 865 of Rite Aid stores to get the deal through.

Read the full transcript

27:26But that's not enough. The Federal Trade Commission fears the deal will make Walgreens so powerful It could bully even the biggest pharmacy benefit managers into paying more for prescriptions. So, Bessina changes tack. In June 2017, he dramatically scales back the proposed deal and instead pays$5.5 billion to buy 2 ,200 of its stores, fewer than half the stores Bessina originally targeted. The regulators greenlight the plan, but the drugstore giants are running out of rival pharmacy chains to buy. They need new options, and CVS sees a very rich prospect getting into health insurance. It's a landmark merger that could change the way millions of Americans get health care and prescription drugs.

28:18CVS agreeing to buy Aetna for$69 billion means for the first time ever, one company will own and control an insurance provider, a retail pharmacy chain, and a pharmacy benefit manager. The buyout of Aetna shocks the healthcare industry. Never before has a pharmacy chain owned a health insurer, let alone a health insurer and a pharmacy benefit manager. Aetna is one of the nation's biggest health insurers. It provides cover for almost 39 million people. And by buying it, CVS is now more healthcare company than retailer. CVS Health is camped out in every step of the twisty drug supply chain. It owns a major insurer, America's biggest chain of pharmacies, the nation's leading pharmacy benefit manager, Caremark, and its in-store minute clinics.

29:13CVS has created a lucrative closed circuit of healthcare. It has an interest in nearly every part of the pharmaceutical supply chain. And as the billions gush through that system, CVS can profit at almost every juncture. It's a bold move, one that Walgreens will be hard-pressed to counter, especially given that its past missteps will come back to haunting.

29:45As business owners and managers, you use software for your business every day. You use one piece of software to manage your customers, another to manage your employees, another to manage your finances, and the list goes on. You buy these pieces independently and hope they fit neatly together like a puzzle. And then you find out the hard way that they don't, and you end up with a mess at the heart of your business operations. Does any of this sound familiar? Well, fortunately, Zoho offers a solution to this chaos. It's called Zoho One. Zoho One is a suite of around 50 pre-integrated business applications that fit together beautifully.

30:23So instead of dealing with disparate software from multiple vendors with multiple contracts and price points, you deal with one vendor with all the pieces of the business software puzzle neatly put together offered at a very attractive price. Now, if this sounds interesting to you, you gotta check out Zoho One at Zoho.one. That's Z-O-H-O dot O-N-E. With Zoho, you're not just licensing apps. You're licensing peace of mind. Let's say hypothetically, or maybe not so much, I'm developing a new podcast that needs an assistant producer, someone who knows how to brainstorm subjects to talk about, find guests to bring in.

31:05That's a tall order. In other words, it's a job for Indeed-sponsored jobs. Spend more time interviewing candidates who check all your boxes. And, you know, listeners of this show will get a$75 sponsored job credit to help you get your job the premium status it deserves at Indeed.com slash businesswars. Just go to Indeed.com slash businesswars right now and support our show by saying you heard about Indeed on this podcast. Indeed.com slash businesswars. Terms and conditions apply. Hiring? Do it the right way with Indeed.

31:5348-year-old Derek steps through the doors of his local CVS store and wonders why Aetna sent him here. It's January 2019, and he's a regular at this CVS in Spring, Texas. He comes here to get his diabetes medication. He's walked its gray carpets and wrestled with its long, snaking receipts many times. But today, he's got no prescription to fill, and he doesn't need bottled water, shaving cream, or toilet paper. Instead, he's here for something no CVS offered until two weeks ago. The Health Hub. Derek spots it immediately. It takes up a fifth of the store. The words Health Hub are written in huge white letters on its light blue walls.

32:35Derek approaches. A smiling employee greets him. Howdy, sir. Welcome to the health hub. I'm the care concierge. How may I help you? Derek blinks. Sorry, a concierge? Yeah, I can help you book appointments with our nurse practitioners and our dietician, answer basic questions about vaccinations, that sort of thing. So, like a doctor's receptionist, right? Kinda. Okay. Well, I need a diabetic retinopathy check. A guy I spoke with at my insurer, Aetna, told me to come here instead of going to my physician like I usually do. But I don't think he understood, actually. You're in the right place. We do those checks.

33:17Derek arches an eyebrow. Drug stores giving flu shots and checking for pink eye is one thing. But to him, this doesn't seem like it's in CVS's wheelhouse. Uh, listen, I just want to be clear. I need a diabetic retinopathy check. It's to make sure I don't go blind because of my diabetes, and I just need to make... I really do offer that test here. It's part of the services Health Hub offers. Do you want me to book you in? Uh, sure. Derek wonders if he's dreaming. When he was a kid in the 1990s, CVS was primarily a convenience store. Now, it's competing with his doctor. He looks at the concierge.

33:58So, uh, what else do you do here? Well, we've got a wellness room where we have Zumba nutrition classes. We have an on-site dietician. We do immunizations, fit sleep apnea masks, and give advice on health insurance navigation. How does tomorrow at 10 a.m. work for your retinopathy check? Derek nods. The health hub is certainly quicker and more convenient than a trip to his physician. And soon, CVS will be adding health hubs to hundreds of stores nationwide. But Walgreens is looking to go one better. Instead of competing with physicians' offices, it's going to put physicians into its stores.

34:44Early 2020, Walgreens headquarters, Deerfield, Illinois. In a meeting room, Stefano Pesina listens as several Walgreens executives argue for a big acquisition. There's a natural intersection between retail pharmacies and primary care physicians. They both treat people from birth to death and deal with all the conditions. Now, putting them in the same place, that's a winning combination. And we think Village Medical at Walgreens is the right model to tap into that. Right now, Village Medical at Walgreens only exists in five stores in the Houston area. It's a partnership between Walgreens and Village MD, a Chicago-based provider of primary care services.

35:24And unlike CVS's health hubs and minute clinics, Village MD has real doctor's offices inside Walgreens. The executive smiles as he wraps up the presentation. Given the amount of time and investment required to build these services ourselves, our recommendation is to buy Village MD. Pesina sits up. No, no, we don't buy. We invest. The team looks disappointed. But Stefano, it's tough to make partnerships work effectively. Come on. It'll work because we have the retail space for them to rent and the money to invest in them. We help them grow so that our investment grows, and then, when the time comes, Village MD does an IPO, and we make a lot of money.

36:09The team isn't surprised. Despite his reputation as a man who buys companies like he's collecting Pokemon cards, he's not interested in following CVS's strategies of punching its way into the healthcare industry with big acquisitions. Piscina sees partnership deals as the best and cheapest way to transform the business. Decision made, Walgreens sinks a billion dollars into Village MD to get a 33 % stake and prepares to start adding village medical offices at Walgreens nationwide. It's a good plan, but it's about to be tested by an unforeseen event.

36:55It's March 2020 in Shrewbury, Massachusetts. At the local CVS, a large white tent now takes up much of the parking lot, And beneath it, employees wearing protective gear and masks are waiting. This is CVS's first drive-through coronavirus test site, and it's dedicated to testing first responders and health care workers. The driver stops at the entrance to the lot and rolls down the window. Hi, I got a test appointment. Okay, first I need to check your temperature. The worker points a handheld infrared thermometer at the man's forehead. The reading indicates a fever. The employee instinctively feels uneasy.

37:36COVID-19's raced across the entire world in a matter of weeks, and there are few details about how it spreads and the risks it poses. The employee points toward the big tent. Drive over there, you get a nasal swab. You do that in your vehicle, then drop it off at the end. Results take 24 hours. The driver moves off. Soon, CVS will be handling more than 1 ,000 COVID tests every day at mass test sites, just like this. By June 2020, the chain will have tested 213 ,000 people. By the year's end, it'll have tested 9 million people. And it's much the same story over at Walgreens. As they transformed themselves, both drugstores found themselves playing an indispensable role in the pandemic, as they and their pharmacists opened testing sites, delivered prescription refills to people's homes, and vaccinated a nation.

38:33It's a sign of the times that millions of Americans didn't go to their doctors or a local hospital to get their COVID shots. They went to CVS and Walgreens. But while the pandemic saw the two firms race to the rescue, a darker side to their status as the nation's pharmacists was playing out in courts nationwide. The country's three largest pharmacy chains, CVS, Walgreens, and Walmart, have agreed to pay more than$12 billion to resolve thousands of lawsuits, accusing them of mishandling opioid painkillers. Beginning in 2017, state and local governments accused those pharmacies of ignoring red flags, that prescriptions were being diverted into illegal trafficking.

39:16They accused the drug makers of downplaying the risk of their opioid pain medicines. Well, CVS, Walmart, and Walgreens declined to comment on that settlement. The November 2022 settlement saw CVS and Walgreens agree to pay$5 billion each for their roles in the wider opioid epidemic. It's left more than half a million people dead and ruined the lives of countless millions. But these multi-billion dollar settlements also underline how these companies are now central to America's health care system. The decisions of these two companies now shape the entire health care system in the United States.

39:53CVS's dual role as pharmacist and insurer and Walgreens' efforts to put primary care into retail spaces have changed the way we care for ourselves and for our loved ones. CVS Health now generates most of its money from its health insurer, Aetna, and its pharmacy benefit manager, Caremark. Walgreens Boots Alliance remains more focused on its drugstores, but now has a majority stake in Village MD, which gives it greater exposure to the health care market. At CVS and Walgreens, it's hard to miss all the people in the stores rolling up their sleeves for shots and getting checkups for chronic conditions.

40:32But it now appears that convenience stores are the new frontier in health care, and it's tough to know where it will end.

40:47From Wondery, this is episode four of CBS vs. Walgreens for Business Wars. A quick note about recreations you've been hearing. In most cases, we can't know exactly what was said, those scenes or dramatizations, but they're based on historical research. I'm your host, David Brown. Tristan Donovan of Yellow Ant Media wrote this story. Karen Lowe is our senior producer and editor. Edited and produced by Emily Frost. Sound design by Josh Morales. Voice acting by Kerry Kavanagh. Our senior managing producer is Ryan Lohr. Our managing producer is Matt Gant. Our producer is Dave Schilling. Our executive producers are Jenny Lauer-Beckman and Marshall Louis for Wondery.

41:33I'm Indra Varma, and in the latest season of The Spy Who, we open the file on Oleg Gordievsky, the spy who outran the KGB. A rising star in the heart of Soviet power, Gordievsky is secretly feeding MI6 the Kremlin's deadliest secrets. For 11 years, he walked a razor's edge, exposing KGB threats that hastened the Cold War's end and helped prevent nuclear annihilation. But the KGB have a mole of their own. When they discover the truth, Gordievsky's world collapses. MI6 hatch a desperate, high-stakes plan to smuggle him out of Moscow. An escape that could rewrite history. Follow The Spy Who on the Wondery app or wherever you listen to podcasts.

42:23Or you can binge the full season of The Spy Who Outran the KGB early and ad-free with Wondery+.

From the publisher

It’s 2013 and CVS boss Larry Merlo is formulating a plan to wipe two-billion dollars off of the company’s sales by stripping cigarettes from the chain’s shelves.


But while Merlo seeks to forge a tobacco-free future for CVS, over at Walgreens the pressure is mounting on CEO Greg Wasson.


The deal to buy European pharmacy giant Alliance Boots is nearing completion. But the deal’s about to take an unexpected turn that’ll see Walgreens under new management.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

More from Business Wars

All 246 episodes
CVS vs. WalgreensBusiness Wars · 36 min
Listen in VO